Charles, Yann Philippe https://orcid.org/0000-0002-0606-211X
Prost, Solène https://orcid.org/0000-0002-3500-0655
Pesenti, Sébastien https://orcid.org/0000-0003-2230-2811
Ilharreborde, Brice https://orcid.org/0000-0002-7245-8366
Bauduin, Eloïse
Laouissat, Féthi https://orcid.org/0000-0001-8151-7340
Riouallon, Guillaume https://orcid.org/0000-0003-4499-621X
Wolff, Stéphane https://orcid.org/0000-0002-0152-5816
Challier, Vincent https://orcid.org/0000-0002-0074-9244
Obeid, Ibrahim https://orcid.org/0000-0002-5602-0508
Boissière, Louis
Ferrero, Emmanuelle https://orcid.org/0000-0003-3357-306X
Solla, Federico https://orcid.org/0000-0003-2735-5330
Le Huec, Jean-Charles https://orcid.org/0000-0002-0463-6706
Bourret, Stéphane https://orcid.org/0000-0002-4385-3172
Faddoul, Joe https://orcid.org/0000-0002-8660-4029
Abi Lahoud, Georges Naïm https://orcid.org/0000-0002-5229-0463
Fière, Vincent https://orcid.org/0000-0002-3989-799X
Vande Kerckhove, Michiel https://orcid.org/0000-0002-5810-094X
Campana, Matthieu
Lebhar, Jonathan https://orcid.org/0000-0001-7606-210X
Giorgi, Hadrien https://orcid.org/0000-0002-3580-846X
Faure, Aymeric https://orcid.org/0000-0002-6484-2122
Sauleau, Erik André https://orcid.org/0000-0003-1178-1060
Blondel, Benjamin https://orcid.org/0000-0001-8896-5277
,
Funding for this research was provided by:
SFCR
Article History
Received: 30 September 2021
Revised: 3 December 2021
Accepted: 20 December 2021
First Online: 6 January 2022
Change Date: 17 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00586-022-07170-6
Declarations
:
: Yann Philippe Charles is consultant for Stryker, Clariance, Philips and Ceraver; he received royalties and grants unrelated to this study from Stryker and Clariance. Brice Ilharreborde is consultant for Zimmer Biomet, Medtronic and Implanet. Féthi Laouissat is consultant for Spineart and SMAIO. Guillaume Riouallon is consultant for Medtronic, Stryker and NewClip; he received royalties from Euros. Vincent Challier is shareholder of Follow Health SA and consultant for Clariance. Ibrahim Obeid is consultant for Medtronic and DePuy Synthes; he received grants from DePuy Synthes unrelated to this study and royalties from Clariance, Alphatec and Spineart. Louis Boissière is consultant for Neo and Euros; he received grants from DePuy Synthes unrelated to this study. Federico Solla received funding to attend meetings from Medicrea, Medtronic and Euros. Jean-Charles Le Huec is consultant for Medtronic and BD Bard; he received royalties and grants unrelated to this study from Medtronic. Vincent Fière is consultant for Clariance; he received royalties Medicrea and Clariance. Aymeric Faure is consultant for OSD. Benjamin Blondel is associate editor for OTSR Elsevier-Masson and consultant for Medicrea, Medtronic, Implanet, Vexim Stryker and M. Solène Prost, Sébastien Pesenti, Eloïse Bauduin, Stéphane Wolff, Emmanuelle Ferrero, Stéphane Bourret, Joe Faddoul, Georges Naïm Abi Lahoud, Michiel Vande Kerckhove, Matthieu Campana, Jonathan Lebhar, Hadrien Giorgi and Erik André Sauleau have no conflict of interest.
: Institutional review board approval (FC/2019-91) was obtained. The study was declared at ClinicalTrials.gov ID: NCT04467775.
: Informed consent was obtained from study participants.
: Informed consent for publication of results was obtained from study participants.